A phase II trial with rosiglitazone in liposarcoma patients.
Autor: | Debrock, G.1 Guy.Debrock@zol.be, Vanhentenrijk, V.2, Sciot, R.2, Debiec-Rychter, M.3, Oyen, R.4, Van Oosterom, A.1 |
---|---|
Zdroj: | British Journal of Cancer. 10/20/2003, Vol. 89 Issue 8, p1409-1412. 4p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |